Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEC | Common Stock | Purchase | $348K | +50K | +20.94% | $6.95 | 289K | Jun 14, 2022 | Direct | F1 |
transaction | ATEC | Common Stock | Purchase | $344K | +50K | +17.31% | $6.87 | 339K | Jun 15, 2022 | Direct | F2 |
holding | ATEC | Common Stock | 8.41M | Jun 14, 2022 | See footnote | F3 |
Id | Content |
---|---|
F1 | This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $6.84 to $7.1, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F2 | This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $6.76 to $6.97, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F3 | Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. |